ArticleGlobal spine journal2026
Evaluating the Effects of Inpatient Only (IPO) Policy Changes on Anterior Cervical Discectomy and Fusion: Access and Outcomes Across Payer Groups.
Article in Global spine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study DesignRetrospective Cohort Study.ObjectiveRemoval of anterior cervical discectomy and fusion (ACDF) from Medicare's Inpatient-Only list in 2017 enabled outpatient reimbursement. Although outpatient ACDF is associated with improved outcomes and lower costs, the impact across payer groups remains unclear, particularly for Medicaid patients.MethodsACDF cases from a national database (2016-2022) were analyzed. Payer groups included Commercial, Medicare, and Medicaid. Multivariable regression adjusted for demographics, comorbidity burden, multilevel fusion, year, and region. Outcomes included complications, 90-day readmissions, and costs.ResultsOutpatient ACDF utilization increased over time but remained lowest among Medicaid patients. Across all payer groups, inpatient surgery was associated with worse outcomes and the magnitude of this difference was greatest in Medicaid patients. Thirty-day complications increased from outpatient to inpatient most prominently in Medicaid patients (OR 1.48). A similar pattern was observed for 90-day readmissions, with the largest increase in Medicaid patients (OR 1.49) and cost (-$5,973).DiscussionOutpatient ACDF provides consistent clinical and economic advantages; however, Medicaid patients remain least likely to receive outpatient care despite the greatest potential benefit, highlighting persistent disparities in access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.